Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
2(33%)
Results Posted
200%(2 trials)
Terminated
1(17%)

Phase Distribution

Ph early_phase_1
1
17%
Ph phase_1
1
17%
Ph not_applicable
1
17%
Ph phase_2
1
17%
Ph phase_3
1
17%

Phase Distribution

2

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Early Phase 1First-in-human
1(20.0%)
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
1(20.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

6

all time

Status Distribution
Active(3)
Completed(1)
Terminated(1)
Other(1)

Detailed Status

Active, not recruiting1
Recruiting1
unknown1
Not yet recruiting1
Completed1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
2
Success Rate
50.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (20.0%)
Phase 11 (20.0%)
Phase 21 (20.0%)
Phase 31 (20.0%)
N/A1 (20.0%)

Trials by Status

active_not_recruiting117%
recruiting117%
unknown117%
not_yet_recruiting117%
completed117%
terminated117%

Recent Activity

2 active trials
Showing 5 of 6
not_yet_recruitingearly_phase_1

PICSTAT Pilot Study for CD8 PET/CT-Guided Lifileucel Treatment in Advanced Melanoma

NCT07700121
active_not_recruitingphase_1

A Study of SNDX-5613 in Combination With Intensive Chemotherapy in Participants With Acute Myeloid Leukemias

NCT06226571
recruitingnot_applicable

ABL/JAK Inhibitors With Chemotherapy and Venetoclax for Ph-like ALL

NCT07454226
completedphase_2

Balugrastim (Neugranin) in Breast Cancer Participants Receiving Doxorubicin/Docetaxel

NCT00837265
terminatedphase_3

Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS)

NCT02082522
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT07700121Early Phase 1

PICSTAT Pilot Study for CD8 PET/CT-Guided Lifileucel Treatment in Advanced Melanoma

Not Yet Recruiting
NCT06226571Phase 1

A Study of SNDX-5613 in Combination With Intensive Chemotherapy in Participants With Acute Myeloid Leukemias

Active Not Recruiting
NCT07454226Not Applicable

ABL/JAK Inhibitors With Chemotherapy and Venetoclax for Ph-like ALL

Recruiting
NCT00837265Phase 2

Balugrastim (Neugranin) in Breast Cancer Participants Receiving Doxorubicin/Docetaxel

Completed
NCT02082522Phase 3

Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS)

Terminated
NCT02850822

Effect of Chemotherapy vs No Chemotherapy Pre-transplant to MDS Undergoing Allo-HSCT

Unknown

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6